Figure S4 from TAS-116 (pimitespib), an Oral HSP90 Inhibitor, in Combination with Nivolumab in Patients with Colorectal Cancer and Other Solid Tumors: an Open-Label, Dose-Finding, and Expansion Phase Ib Trial (EPOC1704)
crossref(2023)
关键词
Hsp70 and Hsp90
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要